INKON Life Technology Co., Ltd. announced a private placement of 111,234,705 shares at an issue price of CNY 8.99 per share for the gross proceeds of not more than CNY 999,999,997.95 on August 12, 2022. The transaction will include participation from returning investor Qingdao Yingkang Medical Investment Co., Ltd. The transaction had a holding period of 36 months from the date of announcement. The transaction has been reviewed approved at the 24th (temporary) meeting of the fifth board of directors of the company, and still need to be reviewed and approved by the company's general meeting of shareholders, by the Shenzhen Stock Exchange and by the China Securities Regulatory Commission.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.94 CNY | -0.13% | +7.73% | -25.31% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-25.31% | 701M | |
-20.16% | 16.21B | |
+4.50% | 12.44B | |
+3.98% | 11.58B | |
+4.70% | 10.79B | |
-0.21% | 7.68B | |
+18.43% | 7.06B | |
+4.49% | 6.67B | |
+50.89% | 4.66B | |
-5.12% | 4.25B |
- Stock Market
- Equities
- 300143 Stock
- News INKON Life Technology Co., Ltd.
- INKON Life Technology Co., Ltd. announced that it expects to receive CNY 999.999998 million in funding from Qingdao Yingkang Medical Investment Co., Ltd.